Fundacion Instituto de Reumatologia Fernando Chalem

Statistics

Publications

331

Citations

4.9K

Authors

Location

Bogotá, Colombia

Also known as Fundación Instituto de Reumatología e Inmunología

Fundacion Instituto de Reumatologia Fernando Chalem is a nonprofit institution in Bogotá, Colombia known for rheumatology, medicine, and rheumatoid arthritis.

Homepage ROR

Top concepts

MedicineRheumatologyRheumatoid ArthritisImmunologyAutoimmunityPharmacotherapyAutoimmune DiseasesImmunopathologyOrthopedic SurgeryJoint Disease

Publications

331

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Bente Langdahl, Cesar Libanati, Daria B. Crittenden et al. · The Lancet · 2017 · 467 citations

Medicine, Endocrinology, Pharmacotherapy +14

The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology

Ingrid Möller, I. Janta, Marina Backhaus et al. · Annals of the Rheumatic Diseases · 2017 · 293 citations

Medicine, Anatomy, Radiology +17

Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Marc C. Hochberg, Johanne Martel‐Pelletier, Jordi Monfort et al. · Annals of the Rheumatic Diseases · 2015 · 280 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacotherapy +15

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)

Bernardo A. Pons‐Estel, Eloísa Bonfá, Enrique R. Soriano et al. · Annals of the Rheumatic Diseases · 2018 · 151 citations · Full text

Life Sciences, Immunology, Internal Medicine +10

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones et al. · Arthritis & Rheumatology · 2021 · 134 citations

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 331

Authors

VP
Viviana Parra-Izquierdo
Fundacion Instituto de Reumatologia Fernando Chalem, Colombia
103 publications · 166 citations
7
h-index
PC
Philippe Chalem
Fundacion Instituto de Reumatologia Fernando Chalem, Colombia
32 publications · 491 citations
7
h-index
JJ
Juan José Jaller
Fundacion Instituto de Reumatologia Fernando Chalem, Colombia
16 publications · 513 citations
7
h-index
JJ
Juan José Jaller-Raad
Fundacion Instituto de Reumatologia Fernando Chalem, Colombia
6 publications · 350 citations
6
h-index
PC
Philippe Chalem-Choueka
Fundacion Instituto de Reumatologia Fernando Chalem, Colombia
7 publications · 60 citations
6
h-index

1–5 of 17